Información del artículo
El Texto completo está disponible en PDF
Bibliografía
[1]
J.A. Piedrahita, S.H. Zhang, J.R. Hagaman, P. Oliver, N. Maeda.
Generation of mice carrying a mutant apolipoprotein E-gene inactivated by gene targeting in embryonic stem cells.
Proc Natl Acad Sci USA, 82 (1992), pp. 4471-4475
[2]
A. Plump, J. Smith, T. Hayek, K. Aalto-Setälä, A. Walsh.
Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells.
Cell, 71 (1992), pp. 343-353
[3.]
S.H. Zhang, R.L. Reddick, J.A. Piedrahita, N. Maeda.
Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E.
Science, 258 (1992), pp. 468-471
[4.]
J. Osada, J. Joven, N. Maeda.
The value of apolipoprotein E knockout mice for studying the effects of dietary fat and cholesterol on atherogenesis.
Curr Opin Lipidol, 11 (2000), pp. 25-29
[5.]
M. Tamminen, G. Mottino, J.H. Qiao, J.L. Breslow, J.S. Frank.
Ultraestructure of early lipid accumulation in ApoE-deficient mice.
Arterioscler Thromb Vasc Biol, 19 (1999), pp. 847-853
[6.]
Y. Nakashima, A.S. Plump, E.W. Raines, J.L. Breslow, R. Ross.
ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree.
Arterisoscler Thromb, 14 (1994), pp. 133-140
[7.]
J. Tse, B. Martin-McNaulty, M. Halks-Miller, K. Kauser, V. DelVecchio, R. Vergona.
Accelerated atherosclerosis and premature calcified cartilaginous metaplasia in the aorta of diabetic male Apo E knockout mice can be prevented by chronic treatment with 17 beta-estradiol.
Atherosclerosis, 144 (1999), pp. 303-313
[9.]
A. Paul, L. Calleja, E. Vilella, R. Martínez, J. Osada, J. Joven.
Reduced progression of atherosclerosis in apolipoprotein E-deficient mice with phenylhydrazyne-induced anemia.
Atherosclerosis, 147 (1999), pp. 61-68
[10.]
L. Calleja, M.A. París, A. Paul, E. Vilella, J. Joven, A. Jiménez, et al.
Low-cholesteroland high-fat diets reduce atherosclerotic lesion development in Apo E-Knockout mice.
Arterioscler Throm Vasc Biol, 19 (1999), pp. 2368-2375
[11.]
H.M. Dansky, S.A. Charlton, J.L. Sikes, S.C. Heath, R. Simantov, L.F. Levin, et al.
Genetic background determines the extent of of atherosclerosis in Apo E-deficient mice.
Arterioscler Throm Vasc Biol, 19 (1999), pp. 1960-1968
[12.]
Y. Adan, K. Shibata, W. Ni, Y. Tsuda, M. Sato, I. Ikeda, et al.
Concentration of serum lipids ans aortic lesion size in female and male apo E-deficient mice fed docosahexaenoic acid.
Biosci Biotech Bioch, 63 (1999), pp. 309-313
[13.]
G. Asset, E. Bauge, R.L. Wolff, J.C. Fruchart, J. Dallongeville.
Pinus pinaster oil affects lipoprotein maetabolism in apolipoprotein E-deficient mice.
J Nutr, 129 (1999), pp. 1972-1978
[14.]
D.J. Ormrod, C.C. Holmes, T.E. Miller.
Dietary chitosan inhibits hypercholesterolaemia and atherogenesis in the apolipoprotein Edeficient mouse model of atherosclerosis.
Atherosclerosis, 138 (1998), pp. 329-334
[15.]
W. Ni, Y. Tsuda, M. Sakono, K. Imaizumi.
Dietary soy protein isolate, compared with casein, reduces atherosclerotic lesion area in apolipoprotein E-deficient mice.
J Nutr, 128 (1998), pp. 1884-1889
[16.]
J.L. Witztum.
The oxidation hypothesis of atherosclerosis.
Lancet, 344 (1994), pp. 793-795
[17.]
R. Ross.
The pathogenesis of atherosclerosis.
Nature (Lond), 362 (1993), pp. 801-809
[18.]
C.H. Hennekens.
Antioxidant vitamins and cardiovascular disease: current knowledge and future directions.
Nutrition, 14 (1998), pp. 50-51
[19.]
J.M. Letters, P.K. Witting, J.K. Christison, A.W. Eriksson, K. Pettersson, R. Stocker.
Time-dependent changes to lipids and antioxidants in plasma and aortas of apolipoprotein E knockout mice.
J Lipid Res, 40 (1999), pp. 1104-1112
[20.]
W. Palinski, V.A. Ord, A.S. Plump, J.L. Breslow, D. Steinberg, J.L. Witztum.
Apo E-deficient mice are a model of lipoprotein oxidation in atherogenesis. Demonstration of oxidation-specific epitopes in lesions anf high titers of autoantibodies to malondialdehyde-lysine in serum.
Arterioscler Thromb, 14 (1994), pp. 605-616
[21.]
T. Hayek, B. Fuhrman, J. Vaya, M. Rosenblat, P. Belinky, R. Coleman, et al.
Reduced progression of atherosclerosis in apolipoprotein Edeficient mice following consumption of red wine, or its polyphenols quercetin or catechin, is associated with reduced susceptibility of LDL to oxidation and aggregation.
Arterioscler Thromb Vasc Biol, 17 (1997), pp. 2744-2752
[22.]
M. Rosenblat, P. Belinky, J. Vaya, R. Levy, T. Hayek, R. Coleman, et al.
Macrophage enrichment with the isoflavan glabridin inhibits NADPH oxidase-induced cell-mediated oxidation of low density lipoprotein. A possible role for protein kinase C.
J Biol Chem, 274 (1999), pp. 13790-13799
[23.]
B. Fuhrman, S. Buch, J. Vaya, P.A. Belinky, R. Coleman, T. Hayek, et al.
Licorice extract and its major polyphenol glabridin protect lowdensity lipoprotein against lipid peroxidation: in vitro and ex vivo studies in humans and in atherosclerotic apolipoprotein E-deficient mice.
Am J Clin Nutr, 66 (1997), pp. 267-275
[24.]
R.K. Tangirala, F. Casanada, F. Miller, J.L. Witztum, D. Steinber, W. Palinski.
Effect of the antioxidant N,N’-diphenyl 1,4-phenylendiamine (DPPD) on atherosclerosis in ApoE-deficient mice.
Arterioscler Thromb Vasc Biol, 15 (1995), pp. 1625-1630
[25.]
M.H. Moghadasian, B.M. McManus, D.V. Godin, B. Rodrigues, J.J. Frohlich.
Proatherogenic and antiatherogenic effects of probucol and phytosterols in apolipoprotein E-deficient mice: possible mechanisms of action.
Circulation, 99 (1999), pp. 1733-1739
[26.]
T.S. Lee, M.S. Shiao, C.C. Pan, L.Y. Chau.
Iron-deficient diet reduces atherosclerotic lesions in Apo E-deficient mice.
Circulation, 99 (1999), pp. 1222-1229
[27.]
A. Shaish, J. George, B. Gilburd, P. Keren, H. Levkovitz, D. Harats.
Dietary b-carotene and a-tocopherol combination does not inhibit atherogenesis in an Apo E-deficient mouse model.
Arterioscler Thromb Vasc Biol, 19 (1999), pp. 1470-1475
[28.]
D. Praticò, R.K. Tangirala, D.J. Rader, J. Rokach, G.A. Fitzgerald.
Vitamin E suppresses isoprostane generation in vivo and reduces atherosclerosis in ApoE-deficient mice.
Nat Med, 4 (1998), pp. 1189-1192
[29.]
I. Maor, T. Hayek, R. Coleman, M. Aviram.
Plasma LDL oxidation leads to its aggregation in the atherosclerotic apolipoprotein E-deficient mice.
Arterioscler Thromb Vasc Biol, 17 (1997), pp. 2995-3005
[30.]
S.H. Zhang, R.L. Reddick, E. Avdievich, L.K. Surles, R.G. Jones, J.B. Reynolds, et al.
Paradoxical enhancement of atherosclerosis by probucol treatment in apolipoprotein E-deficient mice.
J Clin Invest, 99 (1997), pp. 2858-2866
[31.]
R. Ross.
Atherosclerosis-An inflammatory disease.
N Engl J Med, 340 (1999), pp. 115-126
[32.]
V. Fuster, L. Badimon, J.J. Badimon, J.H. Chesebro.
The pathogenesis of coronary artery disease and the acute coronary syndromes (1.
N Engl J Med, 326 (1992), pp. 242-250
[33.]
J.H. Qiao, J. Tripathi, N.K. Mishra, Y. Cai, S. Tripathi, X.P. Wang, et al.
Role of macrophage colony-stimulating factor in atherosclerosis: studies of osteopetrotic mice.
Am J Pathol, 150 (1997), pp. 1687-1699
[34.]
T.C. Dawson, W.A. Kuziel, T.A. Osahar, N. Maeda.
Absence of CC chemokine receptor-2 reduces atherosclerosis in apolipoprotein E-deficient mice.
Atherosclerosis, 143 (1999), pp. 205-211
[35.]
R. Elhage, A. Maret, M.T. Pieraggi, J.C. Thiers, J.F. Arnal, F. Bayard.
Differential effects of interleukin-1 receptor antagonist and tumor necrosis factor binding protein on fatty-streak formation in apolipoprotein E-deficient mice.
Circulation, 97 (1998), pp. 242-244
[36.]
D.A. Sukovich, K. Kauser, F.D. Shirley, V. DelVecchio, M. HalksMiller, G.M. Rubanyi.
Expression of interleukin-6 in atherosclerotic lesions of male ApoE-knockout mice: inhibition by 17 beta-estradiol.
Arterioscler Thromb Vasc Biol, 18 (1998), pp. 1498-1505
[37.]
R.J. Aiello, P.A. Bourassa, S. Lindsey, W. Weng, E. Natoli, B.J. Rollins, et al.
Monocyte chemoattractant protein-1 accelerates atherosclerosis in apolipoprotein E-deficient mice.
Arterioscler Thromb Vasc Biol, 19 (1999), pp. 1518-1525
[38.]
S.J. Hwang, C.M. Ballantyne, A.R. Sharrett, L.C. Smith, C.E. Davis, A.M. Gotto, et al.
Circulating adhesion molecules VCAM-1, ICAM-1, and E-selectin in carotid atherosclerosis and incident coronary heart disease cases: the Atherosclerosis Risk In Communities (ARIC) study.
Circulation, 96 (1997), pp. 4219-4225
[39.]
Y. Nakashima, E.W. Raines, A.S. Plump, J.L. Breslow, R. Ross.
Upregulation of VCAM-1 and ICAM-1 at atherosclerosis-prone sites on the endothelium in the ApoE-deficient mouse.
Arterioscler Thromb Vasc Biol, 18 (1998), pp. 842-851
[40.]
K. Iiyama, L. Hajra, M. Iiyama, H. Li, M. DiChiara, B.D. Medoff, et al.
Patterns of vascular cell adhesion molecule-1 and intercellular adhesion molecule-1 expression in rabbit and mouse atherosclerotic lesions and at sites predisposed to lesion formation.
Circ Res, 85 (1999), pp. 199-207
[41.]
D.R. Manka, P. Wiegman, S. Din, J.M. Sanders, S.A. Green, L.W. Gimple, et al.
Arterial injury increases expression of inflammatory adhesion molecules in the carotid arteries of apolipoprotein E-deficient mice.
J Vasc Res, 36 (1999), pp. 372-378
[42.]
C.L. Ramos, Y. Huo, U. Yung, S. Ghosh, D.R. Manka, I.J. Sarembock, et al.
Direct demonstration of P-selectin and VCAM-1 dependent mononuclear cell rolling in early atherosclerotic lesions of apolipoprotein E-deficient mice.
Circ Res, 84 (1999), pp. 1237-1244
[43.]
R.G. Collins, R. Velji, N.V. Guevara, M.J. Hicks, L. Chan, A.L. Beaudet.
P-Selectin or intracellular adhesion molecule (ICAM)-1 deficiency substantially protects against atherosclerosis in apolipoprotein Edeficient mice.
J Exp Med, 191 (2000), pp. 189-194
[44.]
S.S. Patel, R. Thiagarajan, J.T. Willerson, E.T. Yeh.
Inhibition of a-4- integrin and ICAM-1 markedly attenuate macrophage homing to atherosclerotic plaques in Apo E-deficient mice.
Circulation, 97 (1998), pp. 75-81
[45.]
A. Paul, L. Calleja, J. Camps, J. Osada, E. Vilella, N. Ferré, et al.
The continuous administration of aspirin attenuates atherosclerosis in apolipoprotein E-deficient mice.
Life Sci, 68 (2000), pp. 457-465
[46.]
R. Elhage, F. Bayard, V. Richard, P. Holvoet, N. Duverger, C. Fievet.
Prevention of fatty streak formation of 17 beta-estradiol is not mediated by the production of nitric oxide in apolipoprotein E-deficient mice.
Circulation, 96 (1997), pp. 3048-3052
[47.]
R. Elhage, J.F. Arnal, M.T. Pieraggi, N. Duverger, C. Fievet, J.C. Faye, et al.
17 beta-estradiol prevents fatty streak formation in apolipoprotein E-deficient mice.
Art Thromb Vasc Biol, 17 (1997), pp. 2679-2684
[48.]
V.J. Dzau.
Cell biology and genetics of angiotensin in cardiovascular disease.
J Hypertens, 12 (1994), pp. 3-10
[49.]
S. Keidar.
Angiotensin, LDL peroxidation and atherosclerosis.
Life Sci, 63 (1998), pp. 1-11
[50.]
S. Keidar, J. Attias, R. Heinrich, R. Coleman, M. Aviram.
Angiotensin II atherogenicity in apolipoprotein E deficient mice is associated with increased cellular cholesterol biosynthesis.
Atherosclerosis, 146 (1999), pp. 249-257
[51.]
S. Keidar, J. Attias, J. Smith, J.L. Breslow, T. Hayek.
The angiotensin–II receptor antagonist, losartan, inhibits LDL lipid peroxidation and atherosclerosis in apolipoprotein E-deficient mice.
Biochem Bioph Res Co, 236 (1997), pp. 622-625
[52.]
T. Hayek, J. Attias, J. Smith, J.L. Breslow, S. Keidar.
Antiatherosclerotic and antioxidative effects of captopril in apolipoprotein E-deficient mice.
J Cardiovasc Pharm, 31 (1998), pp. 540-544
[53.]
S. Keidar, J. Attias, R. Coleman, K. Wirth, B. Scholkens, T. Hayek.
Attenuation of atherosclerosis in apolipoprotein E-deficient mice by ramipril is dissociated from its antihypertensive effect and from potentiation of bradykinin.
J Cardiovasc Pharm, 35 (2000), pp. 64-72
Copyright © 2001. Sociedad Española de Arteriosclerosis y Elsevier España, S.L.